INTRODUCTION
Mammary glands are anatomical structures that distinguish mammals from all other animals and secrete milk for offspring. These organs are considered composite secretory organs and are made up of various types of cells, including epithelial cells, adipocytes, fibroblasts, and vascular endothelial cells (Macias & Hinck, 2012 ). There are three major stages of mammary gland development: embryonic, pubertal, and reproductive stages. In embryonic mammary gland development, the epithelial and surrounding stromal compartments derived from embryonic ectoderm and mesoderm are formed.
The epithelial placodes of ectoderm formation during early embryo development give rise to the mammary gland structures during morphogenesis (Pispa & Thesleff, 2003) . The placodes fundamentally regulate epithelial-mesenchymal interactions and generate the rudimentary ductal structure of the gland present at birth. The puberty and reproductive stages of mammary gland development occur continuously through hormonal regulation associated with pubertal growth, pre-gnancy, lactation, and involution. At birth, the mammary gland is a rudimentary structure consisting of only a few small ducts. These small ducts can grow allometrically following the growth phase and undergo expansion, called ductal morphogenesis, until puberty. Puberty in mammals initiates morphogenesis of branched structures in the mammary gland; this process is mutually regulated by growth hormone (GH), estrogen, and insulin-like growth factor (IGF)-1 to generate a ductal tree (Howlin et al., 2006) . During pregnancy, alveoli of the mammary glands, which secrete milk, are generated through combined action of progesterone and prolactin (PRL). In the mature structure, short branched ducts are controlled by progesterone; however, alveologenesis occurs only during pregnancy through induction by PRL and progesterone. PRL continually stimulates this process until the lactogenesis stage. When the levels of progesterone and PRL increase in the serum, branched alveoli are developed, and adipose tissue and blood flow are increased.
After achieving milk production, PRL is decreased, and involution, defined as remodeling back to the original adult state, occurs. In bovines, colostrum is secreted during late gestation and for the first few days after calving. In this review, we will focus on the IGF pathway and its role in developmental processes and involute interactions in bovine mammary glands components.
The IGF Pathway in Bovine Mammary Glands
The , 1996) . Bovine mammary epithelial cells have been reported to express all three IGF receptors (Hadsell et al., 1990) , to synthesize IGFBPs (Gibson et al., 1999) , and to produced IGF-II (Baumrucker et al., 1993) . IGF-1 mRNA is expressed in mammary glands of pregnant and lactating cows (Glimm et al., 1992; Sharma et al., 1994) , whereas cultured primary mammary gland cells do not exhibit IGF-1 expression.
Recent studies have suggested that IGF-I plays a critical role in growth hormone (GH)-induced mammary ductal growth.
The IGF and GH interaction is important for regulation of mammalian epithelial cell proliferation and differentiation. IGF-I is circulated through its interaction with GH, which is the major inducer of alveolar growth (Kleinberg, 1997). There are correlations between IGF-I and GH expression, and these correlations may directly mediate mammary growth (Ruan et al., 1992) . Additionally, GH has been shown to induce IGF-I expression in mammary tissue (Ruan et al., 1995) . Furthermore, IGF-I can promote ductal development in implanted mammary glands and synergizes with estrogen to support the generation of terminal end buds (TEBs) and ductal elongation in ovariectomized mice (Ruan et al., 1995; Kleinberg, 1997) . IGFs are potential mediator involved in the regulation of cell proliferation and apoptosis.
Several studies have reported that IGF-I and IGFR interactions are associated with cell proliferation and apoptosis through inhibition of Wnt signaling (Richard-Parpaillon et al., 2002; Rota & Wood, 2015) . IGF may specifically influence IGF-1R owing to its greater binding affinity than IGF-II or insulin (Jones & Clemmons, 1995) . Moreover, IGF-IIR binds more specifically to IGF-II than IGF-I and does not bind with insulin (Massague et al., 1982; Rechler & Nissley, 1985) .
In general, mammary gland development is characterized by and inhibiting proliferation in type I IGF receptor-knockout mice (Valentinis et al., 1995) . Recent studies have demonstrated that IGFBP-3 regulates transforming growth factor (TGF)-β during programmed cell death through interactions between p53 and IGF-independent signaling (Rajah et al., 1997) . Additionally, the TGF-β receptor can interact with IGFBP-3 (Leal et al., 1997) . Moreover, IGFBP-5 has been shown to activate DNA synthesis in osteoblasts through a pathway independent of IGF-I (Andress, 1995) . Both IGFBP-3 and -5 contain a putative nuclearlocalization sequence (NLS) (Radulescu, 1994) and have been shown to be expressed in the nuclei using immunelogical localization methods (Jaques et al., 1997; Schedlich et al., 2000) . These results suggest that IGFBPs can also contribute to intracellular functions, such as proliferation, apoptosis, and cell migration. Thus, these observations also provide insights into whether the high concentrations of IGFBP-5 in bovine milk interact with IGF-dependent or -independent pathways. In human milk production, IGFBP-2 is more highly expressed than IGFBP-1 and IGFBP-3 (Erickson et al., 1993; Donovan & Odle, 1994) , and IGFBP-1 and IGFBP-3 are present at lower concentrations than IGFBP-2 in human milk. Porcine milk contains IGFBP-1-4. mRNAs encoding IGFBP-2 and -3 are expressed in porcine Effects of the Insulin-like Growth Factor Pathway on the Regulation of Mammary Gland Development Dev. Reprod. Vol. 20, No. 3 September, 2016 183 mammary glands (Simmen et al., 1988) . Thus, IGFBP-2 and -3 in milk is derived from the mammary glands. In bovine serum, IGFBP-2 is highly expressed during the early lactation stage and decreased during the dry period (Vicini et al., 1991) . Rat milk contains IGFBP-2-4, as detected by western blotting. IGFBP-2 is not expressed in maternal serum, but is expressed in lactating mammary glands, suggesting that IGFBP-2 is synthesized in mammary glands. IGFBP-4 expression has been identified in rat mammary glands, although the concentration is lower than that in serum (Donovan et al., 1995 (Travers et al., 1996) . Of all the hormonal changes that occur during the involution stage, PRL is able to influence only IGFBP-5 synthesis, suggesting that the prolactin is a potential inhibitor of IGFBP-5.
CONCLUSION
In bovine mammary glands, mammary gland development occurs through complex regulation of the IGF pathway.
Although IGF pathway ligands (IGF-I, IGF-II, and insulin) affect various cellular mechanisms, including proliferation, migration, and apoptosis, the roles of these ligands in mammary gland development depend on associations with their specific receptors, e.g., IGFBPs and IGF-R. 
